Huangma Technology(603181)
Search documents
皇马科技:皇马科技第七届董事会第十四次会议决议公告
2024-10-25 09:31
证券代码:603181 证券简称:皇马科技 公告编号:2024-035 浙江皇马科技股份有限公司 第七届董事会第十四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 浙江皇马科技股份有限公司(以下简称"公司")第七届董事会第十四次会 议通知已于 2024 年 10 月 18 日以通讯等方式发出,会议于 2024 年 10 月 24 日下 午在子公司会议室以现场结合通讯表决方式召开。本次会议由公司董事长王伟松 先生主持,应参会董事 9 人,实际参会董事 9 人,公司监事、高级管理人员列席 了本次会议。 本次会议的召集、召开、表决程序符合《中华人民共和国公司法》、《公司 章程》等有关规定,会议形成的决议合法有效。 表决结果:9 名同意,占出席会议的董事人数的 100%;0 名反对;0 名弃权。 (二)审议通过《关于与关联人共同出售参股公司股权的议案》 本议案已经公司第七届董事会独立董事专门会议第二次会议审议通过,并同 意将此项议案提交公司董事会审议。 独立董事发表意见如下:独立董事认为本次关联 ...
皇马科技:皇马科技关于与关联人共同出售参股公司股权的公告
2024-10-25 09:28
证券代码:603181 证券简称:皇马科技 公告编号:2024-037 出售标的名称:浙江皇马科技股份有限公司(以下简称"皇马科技"、"公 司")的参股公司浙江中科亚安新材料有限公司(以下简称"中科亚安") 股权 关联交易事项:公司与关联人王伟松先生共同出售各自持有的中科亚安 公司股权给同一第三方自贡中天胜新材料科技有限公司(以下简称"中 天胜")。本次交易构成上市公司放弃优先购买权的关联交易,未构成重 大资产重组。 特别风险提示:本次交易完成后,中科亚安不再是皇马科技的联营公司, 皇马科技和关联人王伟松先生各自持有的中科亚安股权比例将变更为 0, 敬请广大投资者注意投资风险。 | 转让方 | 转让前持有的 | 拟转让股 权数量 | 拟转让股 权原成本 | 本次股权转 让价格的计 | 股权转让 价格 | 受让方 | | --- | --- | --- | --- | --- | --- | --- | | | 中科亚安股份 | | (万元) | | | | | | | (万股) | 【注1】 | 算规则 | (万元) | | | 浙江皇马 科技股份 | 24.6154% (对应400.00万股) | 400. ...
皇马科技:皇马科技2024年前三季度主要经营数据公告
2024-10-25 09:28
证券代码:603181 证券简称:皇马科技 公告编号:2024-036 浙江皇马科技股份有限公司 2024年前三季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 浙江皇马科技股份有限公司(以下简称"公司")根据上海证券交易所《上 市公司自律监管指引第3号行业信息披露第十三号——化工》要求,现将2024年 前三季度主要经营数据披露如下: 注:因停产大品种减水剂板块产品,2024 年度起公司不再以大小品种板块 产品为区分。重点披露主营产品(特种功能性及高分子材料表面活性剂)中的战 略性新兴板块大类经营数据,其中该大类目前包括高端功能性电子化学品板块和 功能性新材料树脂板块。公司将功能性电子化学品、UV 光固化、湿电子化学品 用表面活性剂等相关产品归类为高端功能性电子化学品板块,将新能源胶树脂、 MS 树脂、聚醚胺等相关产品归类为功能性新材料树脂板块。 二、主要产品和原材料的价格变动情况 (一)主要产品价格波动情况 | 主要产品 | 2024年前三季度平均 | 2023年前三季度平均 | 变动比例 | | --- ...
皇马科技:皇马科技关于变更签字注册会计师的公告
2024-10-17 08:21
近日,公司收到天健会计师事务所(特殊普通合伙) 出具的《关于变更签 字注册会计师的函》,现将具体情况公告如下: 一、签字会计师变更情况 天健会计师事务所(特殊普通合伙)作为公司聘任的2024年度财务报表和内 部控制审计机构,原指派吴慧女士、戚铁桥先生作为签字注册会计师为公司提供 审计服务。鉴于原签字注册会计师戚铁桥先生工作调整,现委派方俊鸣先生接替 戚铁桥先生作为签字注册会计师继续完成公司2024年度财务报表审计和内部控 制审计相关工作。变更后的签字注册会计师为:吴慧、方俊鸣。 证券代码:603181 证券简称:皇马科技 公告编号: 2024-034 浙江皇马科技股份有限公司 关于变更签字注册会计师的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 浙江皇马科技股份有限公司(以下简称"公司")于2024年4月16日召开第 七届董事会第十次会议审议通过了《关于续聘公司2024年度审计机构的议案》, 并经2023年年度股东审议通过,同意续聘天健会计师事务所(特殊普通合伙)担 任公司2024年度审计机构和内部控制审计机构。具体内 ...
皇马科技(603181) - 2024 Q3 - 季度业绩预告
2024-10-11 08:58
Financial Performance Forecast - The company expects net profit attributable to shareholders to be between 281.63 million yuan and 293.36 million yuan for the first three quarters of 2024, a year-on-year increase of 20% to 25%[2] - Net profit attributable to shareholders after deducting non-recurring gains and losses is expected to be between 276.91 million yuan and 287.24 million yuan, a year-on-year increase of 34% to 39%[2] - The company's net profit attributable to shareholders in the same period last year was 234.69 million yuan, and net profit after deducting non-recurring gains and losses was 206.65 million yuan[4] - The company's earnings per share in the same period last year was 0.41 yuan[5] Sales Volume and Growth - Total sales volume for the first three quarters of 2024 is expected to increase by 24,300 to 26,500 tons compared to the same period last year, a year-on-year increase of 23% to 25%[3] - The company's sales volume in the same period last year was 105,779.51 tons[4] Reasons for Performance Improvement - The main reason for the performance increase is the optimization of the product structure and the focus on the small variety sector, which has driven overall performance growth[6] Forecast Accuracy and Disclosure - The company has no significant uncertainties affecting the accuracy of this performance forecast[7] - The forecast data is preliminary and the specific financial data will be disclosed in the company's official third-quarter report for 2024[8]
皇马科技:皇马科技第二期员工持股计划第一次持有人会议决议的公告
2024-09-09 10:58
证券代码:603181 证券简称:皇马科技 公告编号:2024-032 浙江皇马科技股份有限公司 为确保公司第二期员工持股计划的顺利实施,保障持有人的合法权益,根据 《员工持股计划》及《管理办法》的相关规定,同意设立员工持股计划管理委员 会,作为第二期员工持股计划的日常监督管理机构,代表持有人行使股东权利。 第二期员工持股计划管理委员会由 3 名委员组成,设管理委员会主任 1 人。 第二期员工持股计划第一次持有人会议决议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 浙江皇马科技股份有限公司(以下简称"公司")于 2024 年 9 月 9 日以现场 和通讯相结合的方式召开了公司第二期员工持股计划第一次持有人会议。会议由 公司董事长王伟松先生召集主持,本次会议的召集、召开及表决程序符合《浙江 皇马科技股份有限公司第二期员工持股计划(草案)》(以下简称"《员工持股计 划》")及《浙江皇马科技股份有限公司第二期员工持股计划管理办法》(以下简 称"《管理办法》")的规定。 本次会议共计 46 名员工持股计划份额持有人出席会议, ...
皇马科技:皇马科技关于第二期员工持股计划完成股票非交易过户的公告
2024-09-09 10:58
证券代码:603181 证券简称:皇马科技 公告编号:2024-031 浙江皇马科技股份有限公司 关于第二期员工持股计划完成股票非交易过户的公告 董事会 特此公告。 浙江皇马科技股份有限公司 根据公司于 2024 年 9 月 9 日收到的中国证券登记结算有限责任公司出具的 《过户登记确认书》,公司回购专用证券账户所持有的 1,338.8 万股公司股票, 已于 2024 年 9 月 6 日完成非交易过户至公司第二期员工持股计划证券账户,过 户价格为 4.84 元/股。截至本公告日,公司第二期员工持股计划账户持有公司 股份 1,338.8 万股,占公司总股本的 2.27%。 根据《皇马科技第二期员工持股计划》的规定,员工持股计划的锁定期为 24 个月,自公司公告最后一笔标的股票过户至本期持股计划名下时起算。若本 计划规定的公司业绩考核指标未达成,则标的股票锁定期增加 12 个月。 公司将持续关注员工持股计划的实施进展情况,并按照相关法律法规的规定 及时履行信息披露义务。敬请广大投资者注意投资风险。 根据参与对象实际认购和最终缴款的审验结果,公司本次员工持股计划实际 参与认购员工 46 人,认购公司回购专用证券账户 ...
皇马科技:产品结构调整初见成效,战略性新兴板块快速增长
Tai Ping Yang· 2024-09-03 00:03
Investment Rating - The report maintains a "Buy" rating for the company, Huamao Technology (603181) [1][2][7] Core Views - The company has shown initial success in product structure adjustments, leading to rapid growth in strategic emerging sectors. In the first half of 2024, the company achieved operating revenue of 1.109 billion yuan, a year-on-year increase of 23.65%, and a net profit attributable to shareholders of 191 million yuan, up 26.98% year-on-year [2][5] - The strategic shift from traditional "large varieties" to focusing on "small varieties" has resulted in improved revenue and profitability. In Q2 2024, the company reported operating revenue of 577 million yuan, a year-on-year increase of 24.18%, and a net profit of 103 million yuan, up 44.11% year-on-year [2][5] - New projects and products are expected to support the company's continuous growth. As of June 30, 2024, several new projects are in progress, including a 0.9 million-ton polyether amine technical transformation project and a 200-ton polyimide project aimed at the aerospace sector [2][5] Summary by Sections Financial Performance - In the first half of 2024, the company achieved operating revenue of 1.109 billion yuan, a 23.65% increase year-on-year, and a net profit of 191 million yuan, a 26.98% increase year-on-year [2][5] - For Q2 2024, operating revenue reached 577 million yuan, a 24.18% year-on-year increase, with a net profit of 103 million yuan, reflecting a 44.11% year-on-year growth [2][5] Strategic Initiatives - The company has successfully adjusted its product structure, focusing on strategic emerging sectors, which has led to significant improvements in revenue and profitability [2][5] - The strategic emerging sector achieved sales volume of 22,100 tons and revenue of 285 million yuan in the first half of 2024, with Q2 showing a sales volume of 11,500 tons and revenue of 145 million yuan [2][5] Future Outlook - The company is expected to continue its growth trajectory with new projects and products, having established 16 major segments, including functional new materials and high-end electronic chemicals [2][5] - Earnings per share (EPS) forecasts for 2024, 2025, and 2026 are projected at 0.68 yuan, 0.83 yuan, and 0.99 yuan, respectively [2][3]
皇马科技:重点产品销量提升推动业绩环比增长,看好开眉客工厂建设
Great Wall Securities· 2024-08-28 10:18
Investment Rating - The report maintains a "Buy" rating for the company [1][4][13] Core Views - The company's revenue for the first half of 2024 reached 1.109 billion yuan, a year-on-year increase of 23.65%, with a net profit attributable to shareholders of 191 million yuan, up 26.98% year-on-year [1][2] - The company is focusing on strategic emerging sectors, particularly high-end functional electronic chemicals and functional new material resins, which are expected to drive future growth [2][4] - The construction of the Kaimeike factory is progressing steadily, with significant production capacity expected to contribute to revenue growth [4][2] Financial Summary - Revenue (million yuan): 2022A: 2,182; 2023A: 1,894; 2024E: 2,283; 2025E: 2,762; 2026E: 3,296 [1][8] - Net profit (million yuan): 2022A: 477; 2023A: 325; 2024E: 402; 2025E: 483; 2026E: 582 [1][8] - EPS (yuan): 2022A: 0.81; 2023A: 0.55; 2024E: 0.68; 2025E: 0.82; 2026E: 0.99 [1][8] - The company expects revenue growth rates of 20.5%, 21.0%, and 19.3% for 2024, 2025, and 2026 respectively [4][2] Operational Insights - The company has ceased production of its major water-reducing agent products and is shifting focus to strategic emerging products [2][4] - In the first half of 2024, the sales volume of specialty functional and polymer material surfactants was 84,186.17 tons, with an average price of 13,167.85 yuan/ton, reflecting a slight year-on-year decline of 1.37% [2][4] - The company has multiple ongoing construction projects, including a high-end surface functional new materials project with an annual capacity of 30,000 tons [4][2]
皇马科技:业绩大幅增长,竞争优势凸显
Orient Securities· 2024-08-22 02:38
Investment Rating - The report maintains a "Buy" rating for the company, with a target price of 12.60 CNY, reflecting a 20% premium over the comparable company's valuation of 15 times earnings for 2024 [2][4]. Core Insights - The company's mid-year performance shows significant growth, with a reported revenue of 1.009 billion CNY for the first half of 2024, representing a year-on-year increase of 23.65%. The net profit attributable to the parent company reached 191 million CNY, up 26.98% year-on-year. In Q2 alone, revenue was 577 million CNY, a 24.08% increase, and net profit was 103 million CNY, reflecting a 45.07% growth [1]. - The company's competitive edge is highlighted by its ability to recover from a significant drop in profits due to macroeconomic factors, with a return to profitability driven by product restructuring and new growth initiatives. The non-GAAP net profit for Q2 2024 rebounded to 103 million CNY [1]. - The company is expected to enter a new growth phase, supported by a recovery in industrial activity due to lower overseas energy costs and domestic policies promoting new production capabilities. The upcoming construction and production phase of the third factory is anticipated to further enhance growth prospects [1]. Financial Forecast and Valuation - Earnings per share (EPS) forecasts for 2024-2026 are projected at 0.70 CNY, 0.89 CNY, and 1.07 CNY respectively. The target price corresponds to an 18 times earnings multiple, reflecting the company's superior historical returns and growth certainty compared to peers [2][4]. - The company's revenue is expected to grow from 2.261 billion CNY in 2024 to 3.302 billion CNY by 2026, with corresponding net profits increasing from 414 million CNY to 630 million CNY over the same period [7][9].